Targeting Neuroinflammation in the Piriform Cortex-Amygdala: Enhanced Efficacy of Niosome-Based Sodium Butyrate in Ischemic Stroke
- 21 April 2026
- journal article
- research article
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 21 (1) , 22
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Pathophysiology of cerebral ischemia-reperfusion injury: An overview of oxidative stress and plant-based therapeutic approachesBrain Research, 2024
- Tight junction proteins related to blood-brain barrier and their regulatory signaling pathways in ischemic strokeBiomedicine & Pharmacotherapy, 2023
- Modified middle cerebral artery occlusion model provides detailed intraoperative cerebral blood flow registration and improves neurobehavioral evaluationJournal of Neuroscience Methods, 2021
- HDAC inhibition prevents hypobaric hypoxia‐induced spatial memory impairment through PΙ3K/GSK3β/CREB pathwayJournal of Cellular Physiology, 2021
- Effects of exercise and pharmacological inhibition of histone deacetylases (HDACs) on epigenetic regulations and gene expressions crucial for neuronal plasticity in the motor cortexBrain Research, 2021
- Odor coding in piriform cortex: mechanistic insights into distributed codingCurrent Opinion in Neurobiology, 2020
- Body weight changes and incidence of cachexia after strokeJournal of Cachexia, Sarcopenia and Muscle, 2019
- Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1Journal of the Neurological Sciences, 2017
- Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcomeWiener klinische Wochenschrift, 2015
- Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the anti-proliferative activity on a breast-cancer cell lineInternational Journal of Cancer, 1999